ClinicalTrials.gg
CompletedNCT01125371Updated Jun 24, 2022Results posted

Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women

An interventional study of Computerized brief alcohol intervention + IVR booster calls and Computerized brief alcohol intervention in Alcohol; Harmful Use, Binge Drinking and Risk Behavior, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to female participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-24.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
439
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
Female
01

Study summary

African American (AA) women are disproportionately affected by HIV/AIDs. The major risk factor for HIV acquisition among AA women is high-risk heterosexual sex, including unprotected vaginal and anal sex, and sex with a high-risk partner. Hazardous alcohol use has been associated with high risk sexual behaviors and prevalent gonorrhea among women attending an urban STI clinic, both of which increase a woman's vulnerability to HIV acquisition and transmission. This application proposes a randomized controlled trial (RCT) of a culturally tailored computer-directed brief alcohol intervention (CBI) enhanced with cell-phone booster calls using interactive voice response technology (IVR) and text messages among HIV-infected and at-risk AA women attending an urban STI Clinic. Hazardous drinking AA women (N=450) presenting with STI complaints will be randomized to one of three arms: 1) usual clinical care, 2) clinic-based, CBI, or 3) clinic-based, CBI + 3 booster calls using IVR and text messages. The CBI, an evidence-based based method for behavior change, will use principles of motivational interviewing, to counsel on: 1) alcohol use and 2) associated HIV/STI risk behaviors. Primary outcomes, measured at 3, 6, and 12 month intervals, include alcohol-related risk behaviors (number of binge drinking episodes, drinking days/week, and drinks per occasion), sexual risk behaviors (number of partners, episodes of unprotected vaginal/anal sex, episodes of sex while high), and occurrence of HIV/STI biomarkers. Prior to implementing the RCT, the CBI and IVR software messages will be revised to: 1) include the association between hazardous alcohol use and risky sexual behaviors, and 2) ensure their relevance and acceptability using quantitative/qualitative feedback from a sample of AA women attending a Baltimore City STI clinic. The proposed research focuses on a particularly vulnerable population of urban HIV at-risk and HIV-infected AA women seeking treatment in a public STI clinic and examines two novel BI intervention delivery strategies specifically tailored to be culturally/socially relevant to this minority population. If the intervention(s) prove to be effective, study findings will offer "real life" specialty care clinics a screening and intervention package that is practical, low cost, and easy to implement.

02

Conditions studied

  • Alcohol; Harmful Use
  • Binge Drinking
  • Risk Behavior
  • HIV Infection

Keywords

  • Hazardous alcohol use
  • Binge drinking
  • High risk sexual behaviors
  • HIV risk reduction
03

In context

Binge Drinking

71 studies on the registry are indexed under Binge Drinking; 20 are open to participants now.

This study's enrollment of 439 is above the median of 120 across 64 interventional studies indexed under Binge Drinking.

Browse Binge Drinking studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,815 studies on the registry; 315 are open to participants now.

Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18 years of age or older;
  2. infected or HIV negative and attending the Baltimore City Health Department sexually transmitted infection clinic for STI-related services
  3. Consumes an average of 8 or more drinks per week OR has had two binge drinking episodes (4 drinks/occasion) in the last 3 months
  4. sexually active
  5. Cognitively able to understand proposed research design (10 min screening, followed by random assignment to one of three study groups (if individual fulfills criteria for RCT enrollment);
  6. Able to speak and understand English
  7. Able and willing to receive text messages

Exclusion criteria

Exclusion Criteria:

  1. Pregnant women will be excluded and referred directly to social work for referral to either alcohol or drug treatment due to ethical concerns of randomization to usual care.
  2. Currently enrolled in alcohol or drug treatment.
  3. Non-English Speaking.
  4. Actively Psychotic or have other severe mental health symptoms that would prevent appropriate participation in the brief intervention protocol.
  5. Planning on moving out of the area within 12 months of study entry
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
439 participants (actual)

Study arms

  • Experimental
    Computerized Brief Alcohol Intervention + IVR

    Computer-delivered brief alcohol intervention (CBI) with booster phone calls delivered by IVR+ text messages (TM)

    Behavioral: Computerized brief alcohol intervention + IVR booster calls

  • Active comparator
    Computerized Brief Alcohol Intervention

    Computerized Brief Alcohol Intervention only (CBI)

    Behavioral: Computerized brief alcohol intervention

  • Placebo comparator
    Attention Control

    Attention control

    Behavioral: Attention Control

Interventions

  • BehavioralComputerized brief alcohol intervention + IVR booster calls

    1) Computerized brief alcohol intervention + IVR booster calls: Clinic-based computerized brief alcohol intervention (delivered once) followed by three booster phone calls using interactive voice response technology + text messages

    Also known as: CBI+IVR+TM

  • BehavioralComputerized brief alcohol intervention

    Computerized brief alcohol intervention: Clinic based computer delivered brief alcohol intervention delivered one time

    Also known as: CBI

  • BehavioralAttention Control

    Attention Control: 20 minute attention control condition focused on dental hygiene delivered once

06

What researchers measure

Primary outcomes

  1. Change in Alcohol Use (Heavy Drinking Days)

    Change in alcohol-related risk behavior as assessed by the number of heavy drinking days.

    Time frame: Baseline, 3, 6, and 12 months

  2. Change in Alcohol Use (Drinking Days)

    Change in alcohol-related risk behavior as assessed by the number of drinking days.

    Time frame: Baseline, 3, 6, and 12 months

  3. Change in Alcohol Use (Drinks Per Drinking Day)

    Change in alcohol-related risk behavior as assessed by the standard drinks per drinking day.

    Time frame: Baseline, 3, 6, and 12 months

  4. Change in Alcohol Use (Drinks Per Week)

    Change in alcohol-related risk behavior as assessed by the standard drinks per week.

    Time frame: Baseline, 3, 6, and 12 months

07

Results

Posted Jun 24, 2022

Participant flow

Participant flow — Overall Study
MilestoneComputerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention Control
Started146145148
3 months follow up127131135
6 months follow up125133131
12 months follow up120130129
Completed120130129
Not completed261519

Outcome measures

PrimaryChange in Alcohol Use (Heavy Drinking Days)

Change in alcohol-related risk behavior as assessed by the number of heavy drinking days.

Time frame:
Baseline, 3, 6, and 12 months
Reported as:
Median · heavy drinking days
Change in Alcohol Use (Heavy Drinking Days)
heavy drinking daysComputerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention Control
Baseline6 (2 to 13)6 (3 to 11)6 (2 to 11)
3 months3 (1 to 7)3 (1 to 8)3 (0 to 8)
6 months3 (0 to 7)4 (1 to 8)2 (0 to 8)
12 months2 (0 to 6)2 (0 to 6)3 (1 to 6)
PrimaryChange in Alcohol Use (Drinking Days)

Change in alcohol-related risk behavior as assessed by the number of drinking days.

Time frame:
Baseline, 3, 6, and 12 months
Reported as:
Median · drinking days
Change in Alcohol Use (Drinking Days)
drinking daysComputerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention Control
Baseline9 (5 to 15)9 (6 to 14)8.5 (5.8 to 15)
3 months6.4 (3 to 10)7 (4 to 12)6 (2.1 to 11)
6 months6 (2 to 11)7 (2 to 12)5 (2 to 11)
12 months6 (2 to 11)6 (2 to 11)6 (2 to 10)
PrimaryChange in Alcohol Use (Drinks Per Drinking Day)

Change in alcohol-related risk behavior as assessed by the standard drinks per drinking day.

Time frame:
Baseline, 3, 6, and 12 months
Reported as:
Median · drinks per drinking day
Change in Alcohol Use (Drinks Per Drinking Day)
drinks per drinking dayComputerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention Control
Baseline5.6 (3.2 to 8.8)5.6 (3.3 to 9.3)6.1 (3.7 to 7.8)
3 months3.7 (2.2 to 6.2)4.2 (2.3 to 6.4)4.1 (2.0 to 6.5)
6 months3.8 (1.4 to 6.4)4.4 (2.1 to 6.8)3.8 (1.7 to 6.2)
12 months3.0 (1.5 to 5.7)3.4 (1.4 to 5.6)3.8 (1.4 to 6.5)
PrimaryChange in Alcohol Use (Drinks Per Week)

Change in alcohol-related risk behavior as assessed by the standard drinks per week.

Time frame:
Baseline, 3, 6, and 12 months
Reported as:
Median · drinks per week
Change in Alcohol Use (Drinks Per Week)
drinks per weekComputerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention Control
Baseline12.0 (4.7 to 28.7)12.4 (5.8 to 25.5)12.0 (5.3 to 25.3)
3 months6.5 (2.1 to 13.6)7.0 (2.9 to 15.4)6.4 (1.6 to 16.1)
6 months5.6 (1.1 to 13.1)6.8 (1.4 to 15.7)4.4 (0.9 to 15.7)
12 months4.3 (1.0 to 11.5)5.3 (1.0 to 12.4)5.4 (1.4 to 11.2)

Adverse events

Collected over 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Computerized Brief Alcohol Intervention + IVR1/146 (0.7%)0/146 (0%)0/146 (0%)
Computerized Brief Alcohol Intervention0/145 (0%)0/145 (0%)0/145 (0%)
Attention Control1/148 (0.7%)0/148 (0%)0/148 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
Median32 (25 to 43)31 (25 to 45)31 (24 to 45)31 (25 to 44)
Sex: Female, Male
Sex: Female, Male(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
Female146145148439
Male0000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
African American131125132388
Other15201651
Level of Education
Level of Education(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
< Grade 12424150133
GED or Higher10410498306
Income
Income(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
$0 - 5,000776375215
$5,001 - 10,00023352583
$10,001 - 15,00018242264
$15,001 or more28232677
HIV Positive Status
HIV Positive Status(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
No132129140401
Yes810422
Unsure66416
Illicit Drug Use
Illicit Drug Use(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
Count of participants959397285
Marijuana Use
Marijuana Use(Participants)Computerized Brief Alcohol Intervention + IVRComputerized Brief Alcohol InterventionAttention ControlTotal
Count of participants787271221

10 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Baltimore City Health Department STD Clinic
    Baltimore, Maryland 21205, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2011, a primary completion of Jun 2016 and a completion of Jun 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Jun 2022, 6 years after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 17, 2010
First posted
May 18, 2010
Start
Oct 2011
Primary completionActual
Jun 7, 2016
CompletionActual
Jun 7, 2016
Results first posted
Jun 24, 2022
Last update
Jun 24, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01125371
Responsible party
Sponsor
First posted
May 18, 2010
Start date
Oct 2011
Primary completion
Jun 7, 2016
Completion
Jun 7, 2016
Results posted
Jun 24, 2022
Last update
Jun 24, 2022

Study contacts

Geetanjali Chander, MD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion